Posts Tagged ‘reduction’
New Data Show Patients With Chronic Low Back Pain Maintained Pain Reduction On Duloxetine
New data show patients with chronic low back pain on duloxetine hydrochloride (Cymbalta?) maintained reductions in pain for 41 weeks.[i] In patients who initially responded to duloxetine, this maintenance of pain reduction was accompanied by further reduction in pain that was statistically significant as measured by the Brief Pain Inventory (BPI) average pain rating.
New Data Show Patients With Chronic Low Back Pain Maintained Pain Reduction On Cymbalta(R)
New data show patients with chronic low back pain on Cymbalta(R) (duloxetine HCl) maintained reductions in pain for 41 weeks.(1) In patients who initially responded to duloxetine, this maintenance of pain reduction was accompanied by further reduction in pain that was statistically significant as measured by the Brief Pain Inventory (BPI) average pain rating.
FDA Approves Opioid Pain Reliever With Required Risk Reduction Plan
The U.S. Food and Drug Administration approved Onsolis, medication intended for certain patients with cancer to help manage breakthrough pain – severe flares of pain that break through regular pain medication. Onsolis is in a class of drugs that deliver the potent opioid fentanyl through the mouth’s mucous membranes. Onsolis delivers fentanyl via an absorbable film that sticks to the inside of the cheek.
Withdrawal Of Co-proxamol Linked To Reduction In Suicides And Accidental Poisonings, UK
Withdrawal of the painkiller co-proxamol from the UK market has led to a major reduction in suicides and accidental poisonings involving the drug, without an increase in deaths from other painkillers, finds research published on bmj.com today. Co-proxamol was the most commonly prescribed drug used in suicides and was responsible for 766 deaths between 1997 and 1999 in England and Wales.
Rx Drug Compare
Translator
By N2H